Abbott Laboratories (ABT)
103.70
+1.19
(+1.16%)
USD |
NYSE |
Oct 23, 16:00
103.80
+0.10
(+0.10%)
After-Hours: 20:00
Abbott Laboratories Free Cash Flow : 7.824B for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.824B |
| March 31, 2026 | 7.378B |
| December 31, 2025 | 7.395B |
| September 30, 2025 | 6.917B |
| June 30, 2025 | 6.775B |
| March 31, 2025 | 6.657B |
| December 31, 2024 | 6.351B |
| September 30, 2024 | 6.486B |
| June 30, 2024 | 5.654B |
| March 31, 2024 | 4.923B |
| December 31, 2023 | 5.059B |
| September 30, 2023 | 4.492B |
| June 30, 2023 | 5.488B |
| March 31, 2023 | 6.823B |
| December 31, 2022 | 7.804B |
| September 30, 2022 | 8.541B |
| June 30, 2022 | 8.468B |
| March 31, 2022 | 8.152B |
| December 31, 2021 | 8.648B |
| September 30, 2021 | 9.314B |
| June 30, 2021 | 8.644B |
| March 31, 2021 | 7.609B |
| December 31, 2020 | 5.724B |
| September 30, 2020 | 4.587B |
| June 30, 2020 | 4.564B |
| Date | Value |
|---|---|
| March 31, 2020 | 4.476B |
| December 31, 2019 | 4.498B |
| September 30, 2019 | 3.814B |
| June 30, 2019 | 4.096B |
| March 31, 2019 | 4.45B |
| December 31, 2018 | 4.906B |
| September 30, 2018 | 4.903B |
| June 30, 2018 | 4.816B |
| March 31, 2018 | 4.966B |
| December 31, 2017 | 4.435B |
| September 30, 2017 | 3.991B |
| June 30, 2017 | 3.154B |
| March 31, 2017 | 2.72B |
| December 31, 2016 | 2.082B |
| September 30, 2016 | 1.811B |
| June 30, 2016 | 1.69B |
| March 31, 2016 | 1.753B |
| December 31, 2015 | 1.856B |
| September 30, 2015 | 2.227B |
| June 30, 2015 | 2.367B |
| March 31, 2015 | 2.284B |
| December 31, 2014 | 2.598B |
| September 30, 2014 | 2.968B |
| June 30, 2014 | 2.290B |
| March 31, 2014 | 2.074B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Becton, Dickinson & Co. | 2.533B |
| Boston Scientific Corp. | 3.625B |
| DexCom, Inc. | 1.405B |
| Globus Medical, Inc. | 750.84M |
| Intuitive Surgical, Inc. | 3.598B |